Clinical Indication

Severe Eosinophilic Asthma


In line with NICE TA565 Implementation date 6th June 2019

Date of classification

May 2019


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.